A detailed history of Eagle Claw Capital Managment, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Eagle Claw Capital Managment, LLC holds 2,648 shares of ABT stock, worth $304,493. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,648
Previous 2,848 7.02%
Holding current value
$304,493
Previous $295,000 2.03%
% of portfolio
0.05%
Previous 0.05%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$100.07 - $118.13 $20,014 - $23,626
-200 Reduced 7.02%
2,648 $301,000
Q2 2024

Aug 09, 2024

SELL
$100.73 - $112.44 $3,727 - $4,160
-37 Reduced 1.28%
2,848 $295,000
Q1 2024

May 13, 2024

BUY
$109.52 - $120.96 $21,904 - $24,192
200 Added 7.45%
2,885 $327,000
Q1 2023

May 04, 2023

SELL
$96.86 - $114.01 $196,141 - $230,870
-2,025 Reduced 42.99%
2,685 $271,000
Q4 2022

Feb 09, 2023

SELL
$95.06 - $111.52 $106,942 - $125,460
-1,125 Reduced 19.28%
4,710 $517,000
Q4 2022

Feb 06, 2023

BUY
$95.06 - $111.52 $106,942 - $125,460
1,125 Added 23.89%
5,835 $640,000
Q3 2022

Nov 07, 2022

SELL
$96.76 - $112.03 $96,760 - $112,030
-1,000 Reduced 17.51%
4,710 $456,000
Q2 2022

Aug 08, 2022

SELL
$102.07 - $123.37 $12,758 - $15,421
-125 Reduced 2.14%
5,710 $620,000
Q2 2021

Aug 10, 2021

SELL
$105.79 - $124.53 $81,246 - $95,639
-768 Reduced 11.63%
5,835 $676,000
Q1 2021

May 12, 2021

SELL
$108.84 - $128.23 $9,469 - $11,156
-87 Reduced 1.3%
6,603 $792,000
Q3 2020

Nov 09, 2020

BUY
$91.64 - $111.29 $13,562 - $16,470
148 Added 2.26%
6,690 $728,000
Q1 2020

May 08, 2020

SELL
$62.82 - $91.86 $2,638 - $3,858
-42 Reduced 0.64%
6,542 $517,000
Q3 2019

Oct 22, 2019

BUY
$81.84 - $88.74 $24,552 - $26,622
300 Added 4.77%
6,584 $551,000
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $8,457 - $9,580
129 Added 2.1%
6,284 $454,000
Q3 2018

Nov 14, 2018

BUY
$60.81 - $73.36 $20,492 - $24,722
337 Added 5.79%
6,155 $453,000
Q1 2018

May 18, 2018

BUY
$56.27 - $63.62 $16,881 - $19,086
300 Added 5.44%
5,818 $348,000
Q4 2017

Feb 13, 2018

SELL
$53.68 - $57.47 $26,840 - $28,735
-500 Reduced 8.31%
5,518 $315,000
Q2 2017

Aug 15, 2017

BUY
N/A
6,018
6,018 $294,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Eagle Claw Capital Managment, LLC Portfolio

Follow Eagle Claw Capital Managment, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Claw Capital Managment, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Claw Capital Managment, LLC with notifications on news.